FeesSafety
Pluang+

Wave Life Sciences schedules Q3 2026 earnings call for October 27 with updates on RNA medicine pipeline.

Company Fundamentals
20 Oct 2026, 15:30 WIB
GlobeNewsWire
View Source
Neutral
Wave Life Sciences schedules Q3 2026 earnings call for October 27 with updates on RNA medicine pipeline.

Wave Life Sciences, a biotech company specializing in RNA medicines, will hold a webcast and conference call on October 27, 2026, to discuss its third quarter financial results and provide business updates. The company focuses on RNA-targeting therapies for diseases like obesity, alpha-1 antitrypsin deficiency, and liver disease, with ongoing clinical programs in muscular dystrophy and Huntington's disease. Investors and analysts can access the live event via the company's website, with a replay available afterward. This event is important as it offers insights into the company's progress and future prospects in RNA medicine development.

Wave Life Sciences' upcoming Q3 2026 financial results event is noted here with Pluang's health sector data for context. Of 150 priced health-sector US stocks on Pluang, 81 rose and 62 fell today. Notable movers include Recursion Pharmaceuticals Inc (RXRX) at USD 3.54 with a 1-day change of -1.94% and Pluang order activity showing 72% Sell / 28% Buy, Alcon AG (ALC) at USD 67.41 up 1.94% with 0% Sell / 100% Buy order activity, and Nuvation Bio Inc. Class A (NUVB) at USD 4.40 down 1.79%. Typical hold times range from 11 to 71 days. Data is as of Oct 20, 2026 19:03 WIB.

More News

DICK'S Sporting Goods favored over Coupang for 2027 due to profitability and valuation despite Coupang's growth.

DICK'S Sporting Goods favored over Coupang for 2027 due to profitability and valuation despite Coupang's growth.

Coupang leads South Korea's e-commerce with strong logistics but faces losses and regulatory challenges, including a major data breach. DICK'S Sporting Goods, expanding through Foot Locker acquisition, shows strong profitability, a solid dividend, an...

Market News
Neutral
17 minutes ago
AMD stock soars 140% in 2026, Nvidia lags but both poised for strong earnings growth by 2028.

AMD stock soars 140% in 2026, Nvidia lags but both poised for strong earnings growth by 2028.

In 2026, AMD's stock surged 140% due to strong growth in AI chips and server CPUs, with revenue and earnings expected to continue rising sharply through 2028. Nvidia, despite a 20% stock drop and leadership uncertainty, reported impressive revenue an...

Market News
Neutral
26 minutes ago
Berkshire Hathaway valued at $700 per share, driven by cash, stocks, and growing businesses under CEO Greg Abel.

Berkshire Hathaway valued at $700 per share, driven by cash, stocks, and growing businesses under CEO Greg Abel.

Berkshire Hathaway holds $352 billion in cash and Treasury bills and a $336 billion stock portfolio, covering over half its current share price. CEO Greg Abel's patient management and steady growth in operating businesses, including railroad and util...

Market News
Bullish
47 minutes ago
Gilead raises dividend for 11th year, backed by strong cash flow and expanding drug portfolio.

Gilead raises dividend for 11th year, backed by strong cash flow and expanding drug portfolio.

Gilead Sciences increased its dividend by 3.8% for the 11th consecutive year, supported by strong free cash flow of $10.6 billion over nine months and a conservative payout ratio below 30%. The company maintains a dominant position in HIV therapies w...

Company Fundamentals
Bullish
1 hour ago
Nvidia stock plunges 23% amid CEO resignation and investigations, trading at a record low P/E of 8.

Nvidia stock plunges 23% amid CEO resignation and investigations, trading at a record low P/E of 8.

Nvidia experienced its worst week since 2008, dropping 23% following CEO Jensen Huang's resignation and multiple investigations into chip exports to China. Despite a strong earnings report showing 103% revenue growth and raised guidance, the stock tr...

Market News
Bearish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App